Nostrum Laboratories has voluntarily recalled another lot of metformin HCl extended-release tablets 750 mg dosage, expanding their initial announcement in November 2020. According to the new notice, ...

Metformin, a medication to treat type 2 diabetes, is facing a recall over concerns it has been contaminated with a possible cancer-causing substance. Nostrum Laboratories Inc., the maker of Metformin, ...

Check your medicine cabinet: Viona Pharmaceuticals, Inc. is recalling several lots of the popular medication Metformin Hydrochloride Extended-Release Tablets, USP 750 mg (often used to treat type 2 ...

The drumbeat of US recalls continues for various lots of extended-release metformin due to contamination with unacceptably high levels of a nitrosoamine that pose a cancer risk. On December 28, Viona ...

Two lots of Type 2 diabetes drug metformin made by Bayshore Pharmaceuticals have been recalled for having more carcinogen NDMA than the FDA’s acceptable daily allowance. The lots were sold to ...

Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the consumer level. The Metformin HCl ...

Following an initial recall in June, Marksans Pharma Limited has now issued an expanded recall for its Metformin Hydrochloride extended-release tablets because they may contain N-Nitrosodimethylamine ...

JAN. 13 UPDATE: Viona re-announced this December recall on Friday, but to the consumer level instead of just the retail level. The 23 lots recalled are included in the 33 below. Viona says 10 lots ...

Marksans Pharma Limited of India has expanded a recall it issued in June for Metformin Hydrochloride Extended Release tablets prescribed for people with Type 2 diabetes. The recall includes an ...

The U.S. Food and Drug Administration has asked some pharmaceutical companies to voluntarily recall extended-release metformin, a popular drug used to control high blood sugar in people with Type 2 ...

Following two other recalls from Apotox Corp. and Amneal Pharmaceuticals for the diabetes drug Metformin because of higher than acceptable levels of Nitrosodimethylamine (NDMA), a cancer-causing ...